Search research articles
Contact Us
Filters
Showing results (1-10 of 203) with videos related to
Page
of 21
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
January 25, 2013
Medical treatment of Cushing's disease
Richard A Feelders, Leo J Hofland
Pituitary
|
July 26, 2022
Hypercoagulability in Cushing's syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols
Richard A Feelders, Lynnette K Nieman
Intensive Care Medicine
|
April 9, 2015
What's new on the HPA axis?
Johannes Hofland, Jan Bakker, Richard A Feelders
Nature Reviews. Drug Discovery
|
August 2, 2012
Pasireotide
Richard A Feelders, Uma Yasothan, Peter Kirkpatrick
The Journal of Clinical Endocrinology and Metabolism
|
March 22, 2024
Epigenetic Mechanisms Modulated by Glucocorticoids With a Focus on Cushing Syndrome
Ticiana Paes, Richard A Feelders, Leo J Hofland
Expert Review of Endocrinology & Metabolism
|
February 16, 2019
Measuring cortisol levels in hair: potential clinical applications in Cushing's syndrome
Elisabeth Fc van Rossum, Laura Manenschijn, Richard A Feelders
BMJ Case Reports
|
March 10, 2019
Hyponatraemia and hyperpigmentation in primary adrenal insufficiency
Bernadette Johanna Maria Benner, Jelmer Alsma, Richard A Feelders
Clinical Epidemiology
|
May 7, 2015
Cushing's syndrome: epidemiology and developments in disease management
Susmeeta T Sharma, Lynnette K Nieman, Richard A Feelders
Neuroendocrinology
|
September 11, 2010
Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole
Richard A Feelders, Leo J Hofland, Wouter W de Herder
Acta Oncologica (Stockholm, Sweden)
|
April 19, 2007
Adrenal insufficiency occurring seven years after nephrectomy for renal cell cancer
Jan A M Van Laar, Nicolien Grool, Richard A Feelders
Page
of 21
Search research articles
Search
Showing results (1-10 of 203) with videos related to
Sort By:
Page
of 21
The Journal of Clinical Endocrinology and Metabolism
|
January 25, 2013
Medical treatment of Cushing's disease
Richard A Feelders, Leo J Hofland
Pituitary
|
July 26, 2022
Hypercoagulability in Cushing's syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols
Richard A Feelders, Lynnette K Nieman
Intensive Care Medicine
|
April 9, 2015
What's new on the HPA axis?
Johannes Hofland, Jan Bakker, Richard A Feelders
Nature Reviews. Drug Discovery
|
August 2, 2012
Pasireotide
Richard A Feelders, Uma Yasothan, Peter Kirkpatrick
The Journal of Clinical Endocrinology and Metabolism
|
March 22, 2024
Epigenetic Mechanisms Modulated by Glucocorticoids With a Focus on Cushing Syndrome
Ticiana Paes, Richard A Feelders, Leo J Hofland
Expert Review of Endocrinology & Metabolism
|
February 16, 2019
Measuring cortisol levels in hair: potential clinical applications in Cushing's syndrome
Elisabeth Fc van Rossum, Laura Manenschijn, Richard A Feelders
BMJ Case Reports
|
March 10, 2019
Hyponatraemia and hyperpigmentation in primary adrenal insufficiency
Bernadette Johanna Maria Benner, Jelmer Alsma, Richard A Feelders
Clinical Epidemiology
|
May 7, 2015
Cushing's syndrome: epidemiology and developments in disease management
Susmeeta T Sharma, Lynnette K Nieman, Richard A Feelders
Neuroendocrinology
|
September 11, 2010
Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole
Richard A Feelders, Leo J Hofland, Wouter W de Herder
Acta Oncologica (Stockholm, Sweden)
|
April 19, 2007
Adrenal insufficiency occurring seven years after nephrectomy for renal cell cancer
Jan A M Van Laar, Nicolien Grool, Richard A Feelders
Page
of 21